Home
Conditions
Chronic Lymphocytic Leukemia

Clinical trial condition

Chronic Lymphocytic Leukemia

Explore clinical trials studying Chronic Lymphocytic Leukemia. Study availability and eligibility vary by location and protocol.

528 public trials 91 recruiting studies

Refine in advanced search Browse all conditions

Chronic Lymphocytic Leukemia trial results

Completed

Study of MDX-1342 in Patients With Chronic Lymphocytic Leukemia (CLL)

NCT00593944

Conditions: Chronic Disease, Chronic Lymphocytic Leukemia, Disease Attributes, +14 more
Locations: Dana-Farber Cancer Institute Boston, Massachusetts, United States

Roswell Park Cancer Institute Buffalo, New York, United States

Oncology Consultants, PA Houston, Texas, United States

View Trial Details

Completed

Treatment of Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL/SLL): DNA Microarray Gene Expression Analysis

NCT00001586

Conditions: Chronic Disease, Chronic Lymphocytic Leukemia, Disease Attributes, +14 more
Locations: National Institutes of Health Clinical Center, 9000 Rockville Pike Bethesda, Maryland, United States

View Trial Details

Completed

CFAR Study in Patients With Chronic Lymphocytic Leukemia

NCT00525603

Conditions: Chronic Disease, Chronic Lymphocytic Leukemia, Disease Attributes, +14 more
Locations: The University of Texas M.D. Anderson Cancer Center Houston, Texas, United States

View Trial Details

Completed

Non-Myeloablative Allogeneic Stem Cell Transplantation With Matched Unrelated Donors for Treatment of Hematologic Malignancies, Renal Cell Carcinoma, and Aplastic Anemia

NCT00513175

Conditions: Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia, Adenocarcinoma, +61 more
Locations: University of California San Francisco San Francisco, California, United States

View Trial Details

Completed

Lenalidomide (Revlimid) in Chronic Lymphocytic Leukemia (CLL)

NCT00267059

Conditions: Chronic Disease, Chronic Lymphocytic Leukemia, Disease Attributes, +14 more
Locations: UT MD Anderson Cancer Center Houston, Texas, United States

View Trial Details

Completed

Campath-1H Plus Rituximab for CD52- and CD20- Positive Refractory or Relapsed Chronic Lymphoid Disorders

NCT00071396

Conditions: Chronic Disease, Chronic Lymphocytic Leukemia, Disease Attributes, +15 more
Locations: University of Texas - MD Anderson Cancer Center Houston, Texas, United States

View Trial Details

Completed

Allo Transplantation With Mylotarg, Fludarabine and Melphalan for AML, CML and MDS

NCT00038831

Conditions: Acute Myelogenous Leukemia, Bone Marrow Diseases, Chronic Disease, +20 more
Locations: MD Anderson Cancer Center Houston, Texas, United States

View Trial Details

Completed

Continuous Infusion of Campath-1H Followed by Subcutaneous Injections in Previously Treated Patients With Chronic Lymphocytic Leukemia

NCT00102661

Conditions: Chronic Disease, Chronic Lymphocytic Leukemia, Disease Attributes, +14 more
Locations: UT MD Anderson Cancer Center Houston, Texas, United States

View Trial Details

Completed

Oral Valganciclovir Versus Valacyclovir

NCT00562770

Conditions: Chronic Disease, Chronic Lymphocytic Leukemia, Disease Attributes, +14 more
Locations: The University of Texas M.D. Anderson Cancer Center Houston, Texas, United States

View Trial Details

Completed

LFB-R603 Dose Finding in Patients With Advanced Stage B-Chronic Lymphocytic Leukemia

NCT01098188

Conditions: Chronic Disease, Chronic Lymphocytic Leukemia, Disease Attributes, +14 more
Locations: Clinique Victor Hugo Le Mans, France

Hôpital Hurriez Lille, France

Institut Paoli Calmettes Marseille, France

Hôpital Saint Eloi Montpellier, France

View Trial Details

Chronic Lymphocytic Leukemia

Chronic Lymphocytic Leukemia trial results

Related conditions